Literature DB >> 31042074

Hydrogen-rich saline ameliorated LPS-induced acute lung injury via autophagy inhibition through the ROS/AMPK/mTOR pathway in mice.

Yong Wang1, Jinghua Zhang2, Jinsong Bo1, Xuefen Wang1, Jingnan Zhu1.   

Abstract

IMPACT STATEMENT: Acute lung injury (ALI), a common complication of many serious health issues, such as serious infection, burns, and shock, is one of the most common critical illnesses in clinical practice with a high mortality rate of 30-40%. There are still short of effective prevention and treatment measures. Evidence is growing that hydrogen-rich saline (HRS) may be an effective drug for the prevention and treatment of ALI. However, the mechanisms involved in have not been clearly understood. In this study, we investigated the underling mechanisms by focusing on autophagy regulation. The results showed that HRS ameliorated lipopolysaccharide-induced ALI in mice by inhibiting autophagy over-activation through ROS/AMPK/mTOR pathway. HRS may be a new therapeutic strategy for ALI prevention and treatment in the future.

Entities:  

Keywords:  Acute lung injury; autophagy; hydrogen-rich saline; lipopolysaccharide; mTOR; reactive oxygen species

Mesh:

Substances:

Year:  2019        PMID: 31042074      PMCID: PMC6567588          DOI: 10.1177/1535370219847941

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  30 in total

1.  Progress in modelling acute lung injury in a pre-clinical mouse model.

Authors:  Michael A Matthay; James P Howard
Journal:  Eur Respir J       Date:  2012-05       Impact factor: 16.671

Review 2.  Novel concepts of acute lung injury and alveolar-capillary barrier dysfunction.

Authors:  Susanne Herold; Nieves M Gabrielli; István Vadász
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-09-13       Impact factor: 5.464

Review 3.  Reconciling the chemistry and biology of reactive oxygen species.

Authors:  Christine C Winterbourn
Journal:  Nat Chem Biol       Date:  2008-05       Impact factor: 15.040

4.  Saturated hydrogen saline attenuates endotoxin-induced lung dysfunction.

Authors:  Yan Zhang; Yiming Liu; Jin Zhang
Journal:  J Surg Res       Date:  2015-04-21       Impact factor: 2.192

5.  Hydrogen-rich saline reduces delayed neurologic sequelae in experimental carbon monoxide toxicity.

Authors:  Quiang Sun; Jianmei Cai; Jiangrui Zhou; Hengyi Tao; John H Zhang; Wei Zhang; Xue-Jun Sun
Journal:  Crit Care Med       Date:  2011-04       Impact factor: 7.598

6.  Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.

Authors:  Ikuroh Ohsawa; Masahiro Ishikawa; Kumiko Takahashi; Megumi Watanabe; Kiyomi Nishimaki; Kumi Yamagata; Ken-Ichiro Katsura; Yasuo Katayama; Sadamitsu Asoh; Shigeo Ohta
Journal:  Nat Med       Date:  2007-05-07       Impact factor: 53.440

Review 7.  Regulation mechanisms and signaling pathways of autophagy.

Authors:  Congcong He; Daniel J Klionsky
Journal:  Annu Rev Genet       Date:  2009       Impact factor: 16.830

8.  Hydrogen therapy may be an effective and specific novel treatment for acute graft-versus-host disease (GVHD).

Authors:  Liren Qian; Jianliang Shen
Journal:  J Cell Mol Med       Date:  2013-06-07       Impact factor: 5.310

9.  Isovitexin Exerts Anti-Inflammatory and Anti-Oxidant Activities on Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting MAPK and NF-κB and Activating HO-1/Nrf2 Pathways.

Authors:  Hongming Lv; Zhenxiang Yu; Yuwei Zheng; Lidong Wang; Xiaofeng Qin; Genhong Cheng; Xinxin Ci
Journal:  Int J Biol Sci       Date:  2016-01-01       Impact factor: 6.580

10.  The evolution of molecular hydrogen: a noteworthy potential therapy with clinical significance.

Authors:  Brandon J Dixon; Jiping Tang; John H Zhang
Journal:  Med Gas Res       Date:  2013-05-16
View more
  3 in total

1.  Hydrogen gas (XEN) inhalation ameliorates airway inflammation in asthma and COPD patients.

Authors:  S-T Wang; C Bao; Y He; X Tian; Y Yang; T Zhang; K-F Xu
Journal:  QJM       Date:  2020-12-01

2.  Chrysosplenol D protects mice against LPS-induced acute lung injury by inhibiting oxidative stress, inflammation, and apoptosis via TLR4-MAPKs/NF-κB signaling pathways.

Authors:  Qinqin Zhang; Aozi Feng; Mengnan Zeng; Beibei Zhang; Jingya Shi; Yaxin Lv; Bing Cao; Chenxin Zhao; Mengya Wang; Yifan Ding; Xiaoke Zheng
Journal:  Innate Immun       Date:  2021-11-20       Impact factor: 2.680

3.  Molecular hydrogen is a promising therapeutic agent for pulmonary disease.

Authors:  Zhiling Fu; Jin Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2022-02-15       Impact factor: 3.066

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.